1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Pleural Effusion, Malignant: new trials by email Literature Review of Pleural Effusion, Malignant trials Research Report on Pleural Effusion, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Darbepoetin alfa, Placebo - Non-Small Cell Lung Cancer, Anemia | Phase 3 | Terminated | Amgen | 2549 | 2009-07-17 | 2022-11-30 |
Anemia (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasms (1) · Pleural Effusion (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Lung Diseases (1) · Neoplasms by Site (1) · Pleural Diseases (1) · Pleural Neoplasms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Darbepoetin alfa (1)
Amgen (1)
Argentina (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Croatia (1) · Czechia (1) · Germany (1) · Greece (1) · Hong Kong (1) · India (1) · Ireland (1)